Use of anti-M üllerian hormone testing during ovarian reserve screening to identify women at risk of polycystic ovary syndrome

To assess the applicability of anti-M üllerian hormone (AMH) testing in the identification of women at risk for polycystic ovary syndrome (PCOS) when AMH is used in ovarian reserve screening in the general population.

Source: International Journal of Gynaecology and Obstetrics - June 15, 2016 Category: OBGYN Authors: Lauren Z. Safier, Lisa C. Grossman, Cariann W. Chan, Mark V. Sauer, Rogerio A. Lobo, Nataki C. Douglas Tags: Clinical article Source Type: research